Search results for "Therapeutics"

showing 10 items of 489 documents

Colonization Resistance of the Gut Microbiota against Clostridium difficile

2015

Antibiotics strongly disrupt the human gut microbiota, which in consequence loses its colonization resistance capacity, allowing infection by opportunistic pathogens such as Clostridium difficile. This bacterium is the main cause of antibiotic-associated diarrhea and a current problem in developed countries, since its incidence and severity have increased during the last years. Furthermore, the emergence of antibiotic resistance strains has reduced the efficiency of the standard treatment with antibiotics, leading to a higher rate of relapses. Here, we review recent efforts focused on the impact of antibiotics in the gut microbiome and their relationship with C. difficile colonization, as w…

Microbiology (medical)medicine.drug_classAntibioticsReviewColonisation resistanceBiologyGut floradigestive systemBiochemistryMicrobiologyantibioticsMicrobiologyAntibiotic resistancecolonization resistancemedicinePharmacology (medical)ColonizationGeneral Pharmacology Toxicology and PharmaceuticsPathogenlcsh:RM1-950Clostridium difficileClostridium difficileAntimicrobialbiology.organism_classificationlcsh:Therapeutics. PharmacologyInfectious Diseasesgut microbiota restorationAntibiotics
researchProduct

The Role of Statins on Helicobacter pylori Eradication: Results from the European Registry on the Management of H. pylori (Hp-EuReg)

2021

Statins could increase the effectiveness of Helicobacter pylori eradication therapies due to their anti-inflammatory effect. The aim of this study was to analyze the impact of this therapeutic association in real life. This is a multicenter, prospective, non-interventional study aimed at evaluating the management of H. pylori by European gastroenterologists. Patients were registered in an e-CRF by AEG-REDCap from 2013 to 2020. The association between statin use and H. pylori eradication effectiveness was evaluated through multivariate analysis. Overall, 9988 and 705 patients received empirical and culture-guided treatment, respectively. Overall, statin use was associated with higher effecti…

Microbiology (medical)medicine.medical_specialtyMultivariate analysisHelicobacter pylori statins treatmentRM1-950BiochemistryMicrobiologyArticlestatinsRescue therapyInternal medicineIn real lifeMedicinePharmacology (medical)General Pharmacology Toxicology and Pharmaceuticsstatins ; Helicobacter pylori ; treatmentbiologyHelicobacter pyloritreatmentbusiness.industry<i>Helicobacter pylori</i>StatinStatin treatmentHelicobacter pyloribiology.organism_classificationTreatmentInfectious DiseasesTherapeutics. Pharmacologybusiness
researchProduct

Role of D-Mannose in the Prevention of Recurrent Uncomplicated Cystitis: State of the Art and Future Perspectives

2021

Background: Urinary tract infections (UTI) are highly frequent in women, with a significant impact on healthcare resources. Although antibiotics still represent the standard treatment to manage recurrent UTI (rUTI), D-mannose, an inert monosaccharide that is metabolized and excreted in urine and acts by inhibiting bacterial adhesion to the urothelium, represents a promising nonantibiotic prevention strategy. The aim of this narrative review is to critically analyze clinical studies reporting data concerning the efficacy and safety of D-mannose in the management of rUTIs. Methods: A non-systematic literature search, using the Pubmed, EMBASE, Scopus, Web of science, Cochrane Central Register …

Microbiology (medical)medicine.medical_specialtymedicine.drug_classUTIAntibiotics030232 urology & nephrologyReviewPlaceboBiochemistryMicrobiologylaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialpreventionlawInternal medicineMedicinePharmacology (medical)General Pharmacology Toxicology and PharmaceuticsMedical prescriptionProspective cohort studyAdverse effectcystitistreatmentbusiness.industryStandard treatmentlcsh:RM1-950Infectious DiseasesSystematic reviewlcsh:Therapeutics. Pharmacologyfemale030220 oncology & carcinogenesiscystitis; d-mannose; female; prevention; treatment; urinary tract infections; utiurinary tract infectionsbusinessD-mannoseAntibiotics
researchProduct

Adapting a Phage to Combat Phage Resistance

2020

Phage therapy is becoming a widely recognized alternative for fighting pathogenic bacteria due to increasing antibiotic resistance problems. However, one of the common concerns related to the use of phages is the evolution of bacterial resistance against the phages, putatively disabling the treatment. Experimental adaptation of the phage (phage training) to infect a resistant host has been used to combat this problem. Yet, there is very little information on the trade-offs of phage infectivity and host range. Here we co-cultured a myophage FCV-1 with its host, the fish pathogen Flavobacterium columnare, in lake water and monitored the interaction for a one-month period. Phage resistance was…

Microbiology (medical)phage therapyGLIDING MOTILITYPhage therapyvirusesmedicine.medical_treatmentevoluutioVirulencefish pathogenmedicine.disease_causeBiochemistryMicrobiologyGenomebakteriofagitArticleMicrobiologyBacteriophage03 medical and health sciencesAntibiotic resistancemedicineCRISPRPharmacology (medical)General Pharmacology Toxicology and Pharmaceutics030304 developmental biology11832 Microbiology and virologyInfectivitylääkeresistenssi0303 health sciencesPREDATIONPRODUCTIVITYbiology030306 microbiologylcsh:RM1-950ARMS-RACEPathogenic bacteriakalatauditbiology.organism_classificationEVOLUTIONfagiterapialcsh:Therapeutics. PharmacologyInfectious Diseasesphage resistancecoevolution1182 Biochemistry cell and molecular biologyVIRULENCEHOST-RANGEBACTERIOPHAGEAntibiotics
researchProduct

Does Empagliflozin Modulate Leukocyte–Endothelium Interactions, Oxidative Stress, and Inflammation in Type 2 Diabetes?

2021

Sodium-glucose co-transporter 2 inhibitors (iSGLT2) have been linked to cardiovascular risk reduction in patients with type 2 diabetes (T2D). However, their underlying molecular mechanisms remain unclear. This study aimed to evaluate the effects of empagliflozin, a novel potent and selective iSGLT-2, on anthropometric and endocrine parameters, leukocyte–endothelium interactions, adhesion molecules, ROS production, and NFkB-p65 transcription factor expression. According to standard clinical protocols, sixteen T2D patients receiving 10 mg/day of empagliflozin were followed-up for 24 weeks. Anthropometric and analytical measurements were performed at baseline, 12 weeks, and 24 weeks. Interacti…

Mitochondrial ROScardiovascular riskGPX1medicine.medical_specialtyEndotheliumPhysiologyClinical Biochemistryempagliflozin030209 endocrinology & metabolismLeukocyte RollingInflammationRM1-950030204 cardiovascular system & hematologymedicine.disease_causeBiochemistry03 medical and health sciences0302 clinical medicineInternal medicineEmpagliflozinmedicineoxidative stressMolecular Biologybusiness.industryCell adhesion moleculeCommunicationCell Biologymedicine.anatomical_structureEndocrinologyinflammationtype 2 diabetesTherapeutics. Pharmacologymedicine.symptombusinessOxidative stressAntioxidants
researchProduct

Drug connectivity mapping and functional analysis reveal therapeutic small molecules that differentially modulate myelination

2022

Disruption or loss of oligodendrocytes (OLs) and myelin has devastating effects on CNS function and integrity, which occur in diverse neurological disorders, including Multiple Sclerosis (MS), Alzheimer’s disease and neuropsychiatric disorders. Hence, there is a need to develop new therapies that promote oligodendrocyte regeneration and myelin repair. A promising approach is drug repurposing, but most agents have potentially contrasting biological actions depending on the cellular context and their dose-dependent effects on intracellular pathways. Here, we have used a combined systems biology and neurobiological approach to identify compounds that exert positive and negative effects on olig…

MyelinMiceMyelin SheathNSC Neural stem cellSystems BiologyOPC Oligodendrocyte progenitor cellHigh-Throughput Nucleotide SequencingLINCS The Library of Integrated Network-based Cellular SignaturesCell DifferentiationGeneral MedicineCNS Central Nervous SystemOligodendrogliamedicine.anatomical_structureOligodendrogenesisNFOL Newly formed oligodendrocyteOL OligodendrocyteSignal TransductionSubventricular zoneOptic nerveIn silicoSystems biologyMorpholinesSVZ subventricular zoneContext (language use)RM1-950BiologyArticlemedicinePharmacogenomics The Library of Integrated Network-Based Cellular Signatures/LINCSAnimalsH-LY29 High concentration of LY294002Computer SimulationPI3K/AKT/mTOR pathwayL-LY29 Low concentration of LY294002PharmacologyPI3K/AktTCN TriciribineDose-Response Relationship DrugRegeneration (biology)Multiple sclerosismedicine.diseaseOligodendrocyteOligodendrocyteiNSCs iPSC-derived NSCsTAPs Transiently amplifying progenitorsMice Inbred C57BLMS Multiple SclerosisiPCS induced Pluripotent Stem CellChromonesPharmacogeneticsTherapeutics. PharmacologyMOL Myelinating oligodendrocyteNeuroscienceBiomedicine & Pharmacotherapy
researchProduct

Generación y caracterización de modelos en Drosophila de disfunción cardiaca en distrofia miotónica

2018

La tesis titulada "Generación y caracterización de los modelos de Drosophila de la disfunción cardíaca en la distrofia miotónica" se realiza mediante la combinación de tres artículos publicados. Después de la dificultad respiratoria, la disfunción cardíaca es la segunda causa más común de muerte asociada con la enfermedad neuromuscular distrofia miotónica (DM). A pesar de la participación central de la insuficiencia cardíaca en la DM, los estudios fisiopatológicos sobre los síntomas cardíacos han sido relativamente escasos porque pocos modelos murinos reproducen fielmente la enfermedad cardíaca. En consecuencia, solo un pequeño número de compuestos candidatos se han evaluado en este fenotip…

Myotonic dystrophy Drosophila heart Molecular alterations Therapeutics
researchProduct

Fourth‐generation glucose sensors composed of copper nanostructures for diabetes management: A critical review

2022

Abstract More than five decades have been invested in understanding glucose biosensors. Yet, this immensely versatile field has continued to gain attention from the scientific world to better understand and diagnose diabetes. However, such extensive work done to improve glucose sensing devices has still not yielded desirable results. Drawbacks like the necessity of the invasive finger‐pricking step and the lack of optimization of diagnostic interventions still need to be considered to improve the testing process of diabetic patients. To upgrade the glucose‐sensing devices and reduce the number of intermediary steps during glucose measurement, fourth‐generation glucose sensors (FGGS) have be…

NanostructureMaterials sciencediabetes managementelectrode materialsBiomedical EngineeringReviewsPharmaceutical Sciencechemistry.chemical_elementEarly detectionhybrid copper nanostructuresNanotechnologyRM1-950ReviewB800Chemical engineeringnonenzymatic glucose sensorsDiabetes managementFourth generationGlucose sensorsearly detectionElectrode materialCopperchemistryTP155-156Therapeutics. PharmacologyTP248.13-248.65BiotechnologyBioengineering &amp; Translational Medicine
researchProduct

Medicinal Plants from Near East for Cancer Therapy.

2017

Background: Cancer is one of the major problems affecting public health worldwide. As other cultures, the populations of the Near East rely on medicinal herbs and their preparations to fight cancer. Methods: We compiled data derived from historical ethnopharmacological information as well as in vitro and in vivo results and clinical findings extracted from different literature databases including (PubMed, Scopus, Web of Science, and Google Scholar) during the past two decades. Results: In this survey, we analyzed the huge amount of data available on anticancer ethnopharmacological sources used in the Near East. Medicinal herbs are the most dominant ethnopharmacological formula used among ca…

Near Eastfood.ingredientpharmacognosyNigella sativaReviewWithania somniferatraditional medicine01 natural sciences03 medical and health sciences0302 clinical medicinefoodCitrullus colocynthiscancerPharmacology (medical)Medicinal plantsPharmacologybiologyTraditional medicinelcsh:RM1-950Urticabiology.organism_classificationArum0104 chemical sciences010404 medicinal & biomolecular chemistrylcsh:Therapeutics. Pharmacology030220 oncology & carcinogenesisArtemisiaphytochemistryLiterature surveycomplementary and alternative medicineFrontiers in pharmacology
researchProduct

Investigating the Role of Guanosine on Human Neuroblastoma Cell Differentiation and the Underlying Molecular Mechanisms

2021

Neuroblastoma arises from neural crest cell precursors failing to complete the process of differentiation. Thus, agents helping tumor cells to differentiate into normal cells can represent a valid therapeutic strategy. Here, we evaluated whether guanosine (GUO), a natural purine nucleoside, which is able to induce differentiation of many cell types, may cause the differentiation of human neuroblastoma SH-SY5Y cells and the molecular mechanisms involved. We found that GUO, added to the cell culture medium, promoted neuron-like cell differentiation in a time- and concentration-dependent manner. This effect was mainly due to an extracellular GUO action since nucleoside transporter inhibitors r…

NeuriteCellular differentiationGuanosinePurine nucleoside phosphorylaseRM1-950Nucleoside transporterSettore BIO/09 - Fisiologiachemistry.chemical_compoundneuroblastomaguanine guanosine guanylate cyclase heme oxygenase neuroblastoma protein kinase C purine nucleoside phosphorylase SH-SY5YdifferentiationNucleòsidsExtracellularPharmacology (medical)guaninePharmacologybiologyMarcadors tumoralsNucleosidesSH-SY5YdifferentiationBrief Research Reportheme oxygenasepurine nucleoside phosphorylaseCell biologyguanylate cyclaseguanosinechemistryCell cultureTumor markersSettore BIO/14 - Farmacologiabiology.proteinTherapeutics. PharmacologyNucleosideprotein kinase C
researchProduct